Institute of Rheumatology_Belgrade

Belgrade 11000

2 studies enrolling now · 9 studies all time

What they study most

Arthritis, Rheumatoid, Chronic Cutaneous Lupus Erythematosus, Lupus Erythematosus, Systemic, Lupus Nephritis, Subacute Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus

Studies at this site

• A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Enrolling by invitation
• Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus — Enrolling by invitation
• Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis — Completed
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study — Stopped early
• Study of VIB7734 for the Treatment of Moderate to Severely Active SLE — Completed
• A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus — Completed
• Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis — Completed
• BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis — Completed